Polo Queen Pharma Trade Industry Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 31-05-2024
- Paid Up Capital ₹ 0.50 M
as on 31-05-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
About Polo Queen Pharma Trade Industry
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rahulkumar Sanghai, Prabhas Sanghai, and Udit Sanghai serve as directors at the Company.
- CIN/LLPIN
U24296MH2016PLC273832
- Company No.
273832
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2016
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Polo Queen Pharma Trade Industry?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhas Sanghai  | Director | 03-Mar-2016 | Current |
| Rahulkumar Sanghai | Director | 03-Mar-2016 | Current |
| Udit Sanghai | Director | 03-Mar-2016 | Current |
Financial Performance and Corporate Structure Insights of Polo Queen Pharma Trade Industry.
Polo Queen Pharma Trade Industry Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Polo Queen Pharma Trade Industry?
In 2017, Polo Queen Pharma Trade Industry had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Polo Queen Industrial And Fintech LimitedActive 40 years 5 monthsRahulkumar Sanghai, Prabhas Sanghai and 1 more are mutual person
- Polo Queen Capital LimitedActive 8 years 9 months
Rahulkumar Sanghai, Prabhas Sanghai and 1 more are mutual person
- Polo Queen Solutions LimitedActive 8 years 9 months
Rahulkumar Sanghai, Prabhas Sanghai and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Polo Queen Pharma Trade Industry?
Unlock and access historical data on people associated with Polo Queen Pharma Trade Industry, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Polo Queen Pharma Trade Industry, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Polo Queen Pharma Trade Industry's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
